Moderna (XSWX:MRNA) Long-Term Debt: CHF465 Mil (As of Mar. 2026)


XSWX:MRNA Moderna Inc XSWX:MRNA
62 GF Score
Price CHF57.81
GF Value CHF18.28
! 7 Warning Signs
View Full Analysis

What is Moderna Long-Term Debt?

Moderna XSWX:MRNA 62 Long-Term Debt is CHF465 Mil as of Mar. 2026. GuruFocus rates XSWX:MRNA with a GF Score™ of 62/100 and a GF Value™ of CHF18.28. The stock has 7 warning signs investors should review.

Moderna's Long-Term Debt for the quarter that ended in Mar. 2026 was CHF465 Mil.

Moderna's quarterly Long-Term Debt increased from Sep. 2025 (CHF0 Mil) to Dec. 2025 (CHF470 Mil) but then declined from Dec. 2025 (CHF470 Mil) to Mar. 2026 (CHF465 Mil).

Moderna's annual Long-Term Debt stayed the same from Dec. 2023 (CHF0 Mil) to Dec. 2024 (CHF0 Mil) but then increased from Dec. 2024 (CHF0 Mil) to Dec. 2025 (CHF470 Mil).

Moderna  (XSWX:MRNA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Moderna Long-Term Debt Related Terms

Moderna Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Moderna's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moderna Long-Term Debt Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 470.17

Moderna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 470.17 464.51
XSWX:MRNA
62GF Score
Moderna Inc XSWX:MRNA
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of CHF465 Mil mean?
Moderna (XSWX:MRNA) has a Long-Term Debt of CHF465 Mil as of Mar. 2026.
Is Moderna's Long-Term Debt too high?
Moderna's current Long-Term Debt is CHF465 Mil. Overall, Moderna has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Moderna's Long-Term Debt compare to RPRX and ROIV?
Moderna's Long-Term Debt of CHF465 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Moderna's current Long-Term Debt is CHF465 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moderna stock overvalued right now?
Moderna (XSWX:MRNA) has a current Long-Term Debt of CHF465 Mil. The stock's GF Value™ is CHF18.28, compared to a current price of CHF57.81 — trading 216.2% above its estimated fair value. The current Long-Term Debt is CHF465 Mil. Moderna's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Moderna (XSWX:MRNA), the current Long-Term Debt is CHF465 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moderna (XSWX:MRNA) Overvalued in 2026?

Based on GuruFocus' analysis, Moderna stock appears to be overvalued. The current stock price of CHF57.81 is trading 216.2% above its estimated GF Value™ of CHF18.28.

Key valuation signals for XSWX:MRNA:

  • Long-Term Debt: CHF465 Mil
  • GF Value™: CHF18.28 vs. price of CHF57.81 (216.2% above fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the XSWX:MRNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moderna Business Description

Address 325 Binney Street, Cambridge, MA, USA, 02142
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
62GF Score

Get the complete analysis for XSWX:MRNA

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF57.81
Price
CHF18.28
GF Value